RxDoctor Payments DataLook up a doctor →

Kathryn Kesti, PA

Physician Assistant · Omaha, NENPI 1124651443

Payments from drug & device makers

$34,369in general payments, 2019–2025

Across 1,631 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$15K
  • Novartis$2K
  • UCB, Inc.$2K
  • Livanova USA, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Biogen$1K
  • plus $11K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)300$15,375
Novartis176$1,730
UCB, Inc.155$1,604
Livanova USA, Inc.14$1,522
Teva Pharmaceuticals USA, Inc.121$1,469
Biogen131$1,231
Lundbeck LLC78$1,041
Lilly USA, LLC45$839
Amgen38$799
Neurocrine Biosciences, Inc.57$769
Pfizer55$568
Argenx US, Inc.23$461
Biohaven Pharmaceuticals, Inc.20$427
CSL Behring23$418
Johnson & Johnson(2 entities)27$402
Amneal Pharmaceuticals LLC29$393
Bristol Myers Squibb22$389
Upsher-smith Laboratories LLC17$312
AstraZeneca(2 entities)12$310
Supernus Pharmaceuticals, Inc.37$300
Biohaven Pharmaceutical Holding Company Ltd.31$287
Jazz Pharmaceuticals Inc.14$271
MDD US Operations, LLC24$232
Eisai Inc.13$219
EMD Serono, Inc.7$200
Sanofi11$175
Avanir Pharmaceuticals, Inc.16$172
Axsome Therapeutics, Inc.14$151
Catalyst Pharmaceuticals, Inc.7$144
Neurelis, Inc.5$139
Acadia Pharmaceuticals Inc7$127
ANI Pharmaceuticals, Inc.5$121
Hospira, Inc.6$118
SK Life Science, Inc.6$112
Vanda Pharmaceuticals Inc.4$111
Sunovion Pharmaceuticals Inc.13$109
Merz Pharmaceuticals, LLC5$106
Mallinckrodt Hospital Products Inc.4$99
Tanabe Pharma America, Inc.5$86
Octapharma USA, Inc.4$86
Almatica Pharma LLC3$74
Arbor Pharmaceuticals, Inc.4$67
Grifols USA, LLC2$59
Boston Scientific3$56
Adamas Pharmaceuticals, Inc.3$54
Genentech USA, Inc.2$49
Otsuka America Pharmaceutical, Inc.2$47
GRT US Holding, Inc.2$46
Impel Pharmaceuticals Inc.3$45
Merck3$43
Avion Pharmaceuticals3$42
Alnylam Pharmaceuticals Inc.2$40
Kyowa Kirin, Inc.2$38
Scilex Pharmaceuticals Inc.2$36
GE HealthCare2$33
Avadel CNS Pharmaceuticals, LLC1$32
Takeda Pharmaceuticals U.S.A., Inc.2$31
Idorsia Pharmaceuticals US Inc2$27
Xeris Pharmaceuticals, Inc.2$26
Tonix Medicines, Inc.1$24

How this compares

$34,369 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska →

Medicare billing

Part B allowed, 2024
$127,179
Medicare patients
101
Services billed
18,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Omaha

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →